These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 9414386)
1. Rates of development of methotrexate resistance in heterogeneous mouse mammary tumor cell cultures. Miller BE; Matherly LH; Lehotan M; Heppner GH J Exp Ther Oncol; 1996 Jan; 1(1):30-8. PubMed ID: 9414386 [TBL] [Abstract][Full Text] [Related]
2. Therapeutic perturbation of the tumor ecosystem in reconstructed heterogeneous mouse mammary tumors. Miller BE; Miller FR; Heppner GH Cancer Res; 1989 Jul; 49(14):3747-53. PubMed ID: 2736515 [TBL] [Abstract][Full Text] [Related]
3. [Primary study on establishment of namalwa 12/MTX resistant cell strain and its mechanism]. Chen J; Gu LJ; Ying DM; Shen M; Wu HJ Ai Zheng; 2002 Dec; 21(12):1335-40. PubMed ID: 12520743 [TBL] [Abstract][Full Text] [Related]
4. Relative frequency and kinetic properties of transport-defective phenotypes among methotrexate-resistant L1210 clonal cell lines derived in vivo. Sirotnak FM; Moccio DM; Kelleher LE; Goutas LJ Cancer Res; 1981 Nov; 41(11 Pt 1):4447-52. PubMed ID: 7306968 [TBL] [Abstract][Full Text] [Related]
5. Factors affecting growth and drug sensitivity of mouse mammary tumor lines in collagen gel cultures. Miller BE; Miller FR; Heppner GH Cancer Res; 1985 Sep; 45(9):4200-5. PubMed ID: 4028010 [TBL] [Abstract][Full Text] [Related]
6. Tumor subpopulation interactions affecting melphalan sensitivity in palpable mouse mammary tumors. Miller BE; Machemer T; Lehotan M; Heppner GH Cancer Res; 1991 Aug; 51(16):4378-87. PubMed ID: 1868461 [TBL] [Abstract][Full Text] [Related]
7. Resistance mechanisms to methotrexate in tumors. Bertino JR; Göker E; Gorlick R; Li WW; Banerjee D Stem Cells; 1996 Jan; 14(1):5-9. PubMed ID: 8820944 [TBL] [Abstract][Full Text] [Related]
8. Osteosarcoma cells, resistant to methotrexate due to nucleoside and nucleobase salvage, are sensitive to nucleoside analogs. Cole PD; Smith AK; Kamen BA Cancer Chemother Pharmacol; 2002 Aug; 50(2):111-6. PubMed ID: 12172974 [TBL] [Abstract][Full Text] [Related]
9. Dominance of a tumor subpopulation line in mixed heterogeneous mouse mammary tumors. Miller BE; Miller FR; Wilburn D; Heppner GH Cancer Res; 1988 Oct; 48(20):5747-53. PubMed ID: 3167832 [TBL] [Abstract][Full Text] [Related]
10. Generation of dual resistance to 4-hydroperoxycyclophosphamide and methotrexate by retroviral transfer of the human aldehyde dehydrogenase class 1 gene and a mutated dihydrofolate reductase gene. Takebe N; Zhao SC; Adhikari D; Mineishi S; Sadelain M; Hilton J; Colvin M; Banerjee D; Bertino JR Mol Ther; 2001 Jan; 3(1):88-96. PubMed ID: 11162315 [TBL] [Abstract][Full Text] [Related]
11. Heterogeneity in drug sensitivity among tumor cell subpopulations of a single mammary tumor. Heppner GH; Dexter DL; DeNucci T; Miller FR; Calabresi P Cancer Res; 1978 Nov; 38(11 Pt 1):3758-63. PubMed ID: 698935 [TBL] [Abstract][Full Text] [Related]
12. [Macrophage-mediated induction of drug-resistance variants in a mouse mammary tumor cell line]. Yamashina K Hokkaido Igaku Zasshi; 1986 Jul; 61(4):568-75. PubMed ID: 3758918 [TBL] [Abstract][Full Text] [Related]
13. Evolution of drug resistance in CCRF-CEM human leukemia cells selected by intermittent methotrexate exposure. McGuire JJ; Haile WH; Russell CA; Galvin JM; Shane B Oncol Res; 1995; 7(10-11):535-43. PubMed ID: 8866666 [TBL] [Abstract][Full Text] [Related]
14. Basis of observed resistance of L1210 leukemia in mice: methotrexate, 6-thioguanine, 6-methylmercaptopurine riboside, 6-mercaptopurine, 5-fluorouracil, and 1-beta-D-arabinofuranosylcytosine administered in different combinations. Kim K; Blechman WJ; Riddle VG; Pardee AB Cancer Res; 1981 Nov; 41(11 Pt 1):4529-34. PubMed ID: 7198006 [TBL] [Abstract][Full Text] [Related]
15. Intrinsic resistance to methotrexate in human soft tissue sarcoma cell lines. Li WW; Lin JT; Schweitzer BI; Tong WP; Niedzwiecki D; Bertino JR Cancer Res; 1992 Jul; 52(14):3908-13. PubMed ID: 1377601 [TBL] [Abstract][Full Text] [Related]
16. Methotrexate resistance conferred by transplantation of drug-resistant transgenic marrow cells fractionated bycounterflow elutriation. James R; May C; Diers M; Wagner J; McIvor R Bone Marrow Transplant; 1999 Oct; 24(8):815-21. PubMed ID: 10516690 [TBL] [Abstract][Full Text] [Related]
17. Increasing methotrexate resistance by combination of active-site mutations in human dihydrofolate reductase. Volpato JP; Fossati E; Pelletier JN J Mol Biol; 2007 Oct; 373(3):599-611. PubMed ID: 17868689 [TBL] [Abstract][Full Text] [Related]
18. Methotrexate accumulates to similar levels in animals transplanted with normal versus drug-resistant transgenic marrow. Belur LR; Boelk-Galvan D; Diers MD; McIvor RS; Zimmerman CL Cancer Res; 2001 Feb; 61(4):1522-6. PubMed ID: 11245460 [TBL] [Abstract][Full Text] [Related]
19. Overcoming methotrexate resistance in breast cancer tumour cells by the use of a new cell-penetrating peptide. Lindgren M; Rosenthal-Aizman K; Saar K; Eiríksdóttir E; Jiang Y; Sassian M; Ostlund P; Hällbrink M; Langel U Biochem Pharmacol; 2006 Feb; 71(4):416-25. PubMed ID: 16376307 [TBL] [Abstract][Full Text] [Related]
20. Gene expression profiling of leukemia T-cells resistant to methotrexate and 7-hydroxymethotrexate reveals alterations that preserve intracellular levels of folate and nucleotide biosynthesis. Fotoohi AK; Assaraf YG; Moshfegh A; Hashemi J; Jansen G; Peters GJ; Larsson C; Albertioni F Biochem Pharmacol; 2009 Apr; 77(8):1410-7. PubMed ID: 19426680 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]